Financhill
Back

Protagonist Therapeutics Stock Predictions

Protagonist Therapeutics Stock Forecast

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 18.1% based on the past 6 years of stock performance.
  • Protagonist Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Protagonist Therapeutics Stock Undervalued?
    The current Protagonist Therapeutics [PTGX] share price is $13.49. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 18.1% based on the past 6 years of stock performance.

Protagonist Therapeutics Stock Rating

Sell
50
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics overpriced?

  • Protagonist Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Protagonist Therapeutics Stock Price History

Is PTGX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
protagonist-inc.com

52-Week Data

52-Week High:
30.42
52-Week Low:
6.91

Prediction Charts

Market Cap:
663.69M
Price in USD:
13.49
Volume:
966.32K
Beta:
2.02

Technical Analysis

SMA50:
9.85
SMA100:
9.09
SMA200:
9.65
52-Wk Change:
-48.86%

Stock Predictions

  • Is Protagonist Therapeutics stock public?
    Yes, Protagonist Therapeutics is a publicly traded company.
  • What is the Protagonist Therapeutics stock quote today?
    The Protagonist Therapeutics stock price isĀ 13.49 USD today.
  • How to buy Protagonist Therapeutics stock online?
    You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-9 11.70 11.34 12.06 11.32
Jan-10 11.28 11.76 11.79 11.21
Jan-11 11.74 12.06 12.14 11.40
Jan-12 12.14 12.75 13.11 12.12
Jan-13 12.59 12.17 12.78 11.97
Jan-17 12.18 11.65 12.28 11.57
Jan-18 11.85 11.86 12.32 11.59
Jan-19 11.80 11.83 12.22 11.64
Jan-20 11.94 11.66 12.04 11.43
Jan-23 11.68 11.47 11.79 11.31
Jan-24 11.47 12.70 12.78 11.21
Jan-25 12.49 13.15 13.38 12.22
Jan-26 13.16 13.18 13.37 12.87
Jan-27 13.16 13.49 13.89 12.81

Protagonist Therapeutics Earnings

Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics Forecast Revenue Growth

Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.29 per share.

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.